ciclopirox has been researched along with Candidiasis, Oral in 2 studies
Candidiasis, Oral: Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a pharmacokinetic study, the drug release from mucoadhesive films was prolonged with the maximum plasma concentration at 3." | 1.62 | Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: In vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits. ( Gajdošová, M; Gajdziok, J; Hauptman, K; Jekl, V; Juřica, J; Muselík, J; Vetchá, M; Vetchý, D, 2021) |
| "Ciclopirox olamine (CPO) is a topical wide-spectrum antimycotic agent that possesses antifungal, antibacterial and anti-inflammatory activities." | 1.56 | Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine. ( AbouSamra, MM; Awad, GEA; Mansy, SS; Salama, AH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| AbouSamra, MM | 1 |
| Salama, AH | 1 |
| Awad, GEA | 1 |
| Mansy, SS | 1 |
| Gajdošová, M | 1 |
| Vetchý, D | 1 |
| Muselík, J | 1 |
| Gajdziok, J | 1 |
| Juřica, J | 1 |
| Vetchá, M | 1 |
| Hauptman, K | 1 |
| Jekl, V | 1 |
2 other studies available for ciclopirox and Candidiasis, Oral
| Article | Year |
|---|---|
Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine.
Topics: Adhesives; Administration, Buccal; Agar; Animals; Antifungal Agents; Candidiasis, Oral; Cholesterol; | 2020 |
Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: In vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits.
Topics: Administration, Buccal; Animals; Antifungal Agents; Candidiasis, Oral; Ciclopirox; Drug Liberation; | 2021 |